Payment overview · 2025
General Payments
$8,930.35
64 reported records · 21 companies
Healthcare provider profile · identity verified
Shivani Kumar
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · BOSTON, MA · NPI 1629423017
Verified facts
What the public records show
CMS Open Payments records show Shivani Kumar received $8,930.35 in general payments during 2025 across 64 reported records.
Shockwave Medical, Inc accounted for 63.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 33 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $5,633.84 | 63.1% | 15 | 2025 |
| Bolton Medical Inc | Unresolved — no canonical attribution shown | $724.43 | 8.1% | 14 | 2025 |
| Reflow Medical Inc | Unresolved — no canonical attribution shown | $432.12 | 4.8% | 3 | 2025 |
| PolyNovo North America LLC | Unresolved — no canonical attribution shown | $369.90 | 4.1% | 3 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $319.79 | 3.6% | 5 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $314.77 | 3.5% | 6 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$215.26 | 2.4% | 1 | 2025 |
| Artivion, Inc. | Unresolved — no canonical attribution shown | $195.14 | 2.2% | 1 | 2025 |
| Endologix LLC | Unresolved — no canonical attribution shown | $184.18 | 2.1% | 2 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $183.11 | 2.0% | 2 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $90.20 | 1.0% | 2 | 2025 |
| Innovation Technologies Inc | Unresolved — no canonical attribution shown | $36.22 | 0.4% | 1 | 2025 |
| Access Pro Medical, LLC | Unresolved — no canonical attribution shown | $34.73 | 0.4% | 1 | 2025 |
| Integra LifeSciences Corporation | Unresolved — no canonical attribution shown | $31.86 | 0.4% | 1 | 2025 |
| Organogenesis Inc. | Unresolved — no canonical attribution shown | $31.24 | 0.3% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $30.21 | 0.3% | 1 | 2025 |
| Acera Surgical, Inc. | Unresolved — no canonical attribution shown | $23.88 | 0.3% | 1 | 2025 |
| MIMEDX Group, Inc. | Unresolved — no canonical attribution shown | $22.65 | 0.2% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $20.68 | 0.2% | 1 | 2025 |
| Solventum Corporation | Unresolved — no canonical attribution shown | $18.11 | 0.2% | 1 | 2025 |
| CORDIS US CORP. | Unresolved — no canonical attribution shown | $18.03 | 0.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $3,850.00 | 4 |
| Food and Beverage | $3,746.37 | 58 |
| Travel and Lodging | $1,333.98 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $5,633.84 | 15 | 2025 |
Source payment records
|
|||||
| TREO ABDOMINAL STENT-GRAFT SYSTEM Normalized: treo abdominal stent graft system |
Device | Bolton Medical Inc | $496.86 | 11 | 2025 |
Source payment records
|
|||||
| NOVOSORB BTM Normalized: novosorb btm |
Device | PolyNovo North America LLC | $369.90 | 3 | 2025 |
Source payment records
|
|||||
| COOK Normalized: cook |
Device | Cook Medical LLC | $228.85 | 1 | 2025 |
Source payment records
|
|||||
| VISI-PRO Normalized: visi pro |
Device | Medtronic, Inc. | $215.26 | 1 | 2025 |
Source payment records
|
|||||
| BIOGLUE SURGICAL ADHESIVE Normalized: bioglue surgical adhesive |
Device | Artivion, Inc. | $195.14 | 1 | 2025 |
Source payment records
|
|||||
| PHOTOFIX DECELLULARIZED BOVINE PERICARDIUM Normalized: photofix decellularized bovine pericardium |
Device | Artivion, Inc. | $195.14 | 1 | 2025 |
Source payment records
|
|||||
| Vascular Normalized: vascular |
Device | Artivion, Inc. | $195.14 | 1 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $183.11 | 2 | 2025 |
Source payment records
|
|||||
| General - Vascular Intervention Normalized: general vascular intervention |
Device | Boston Scientific Corporation | $166.86 | 1 | 2025 |
Source payment records
|
|||||
| GELWEAVE Normalized: gelweave |
Device | Bolton Medical Inc | $155.18 | 1 | 2025 |
Source payment records
|
|||||
| AZUR CX DETACHABLE Normalized: azur cx detachable |
Device | Terumo Medical Corporation | $90.20 | 2 | 2025 |
Source payment records
|
|||||
| ZENITH Normalized: zenith |
Device | Cook Medical LLC | $63.94 | 3 | 2025 |
Source payment records
|
|||||
| EkoSonic Normalized: ekosonic |
Device | Boston Scientific Corporation | $44.78 | 1 | 2025 |
Source payment records
|
|||||
| ENROUTE Transcarotid Neuroprotection System Normalized: enroute transcarotid neuroprotection system |
Device | Boston Scientific Corporation | $43.14 | 2 | 2025 |
Source payment records
|
|||||
| RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Normalized: relay thoracic stent graft with plus delivery system |
Device | Bolton Medical Inc | $40.22 | 1 | 2025 |
Source payment records
|
|||||
| IRRISEPT Normalized: irrisept |
Device | Innovation Technologies Inc | $36.22 | 1 | 2025 |
Source payment records
|
|||||
| MATRIDERM Normalized: matriderm |
Device | Access Pro Medical, LLC | $34.73 | 1 | 2025 |
Source payment records
|
|||||
| THORAFLEX HYBRID Normalized: thoraflex hybrid |
Device | Bolton Medical Inc | $32.17 | 1 | 2025 |
Source payment records
|
|||||
| Integra Normalized: integra |
Device | Integra LifeSciences Corporation | $31.86 | 1 | 2025 |
Source payment records
|
|||||
| Integra Dermal Regeneration Template Normalized: integra dermal regeneration template |
Device | Integra LifeSciences Corporation | $31.86 | 1 | 2025 |
Source payment records
|
|||||
| PRIMATRIX Normalized: primatrix |
Device | Integra LifeSciences Corporation | $31.86 | 1 | 2025 |
Source payment records
|
|||||
| APLIGRAF Normalized: apligraf |
Device | Organogenesis Inc. | $31.24 | 1 | 2025 |
Source payment records
|
|||||
| ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter Normalized: enroute enflate transcarotid rx balloon dilatation catheter |
Device | Boston Scientific Corporation | $30.50 | 1 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $30.21 | 1 | 2025 |
Source payment records
|
|||||
| PAXLOVID Normalized: paxlovid |
Drug | PFIZER INC. | $30.21 | 1 | 2025 |
Source payment records
|
|||||
| Varithena Administration Pack Normalized: varithena administration pack |
Device | Boston Scientific Corporation | $29.49 | 1 | 2025 |
Source payment records
|
|||||
| GLIDESHEATH SLENDER Normalized: glidesheath slender |
Device | Terumo Medical Corporation | $29.08 | 1 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $27.00 | 1 | 2025 |
Source payment records
|
|||||
| Restrata Wound Matrix Normalized: restrata wound matrix |
Device | Acera Surgical, Inc. | $23.88 | 1 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $20.68 | 1 | 2025 |
Source payment records
|
|||||
| ACTIV.A.C. Normalized: activ a c |
Device | Solventum Corporation | $18.11 | 1 | 2025 |
Source payment records
|
|||||
| OUTBACK Normalized: outback |
Device | CORDIS US CORP. | $18.03 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $8,930.35 · 64 records | Shockwave Medical, Inc | ACTIV.A.C., APLIGRAF, AZUR CX DETACHABLE, BIOGLUE SURGICAL ADHESIVE, COOK, ELIQUIS, ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter, ENROUTE Transcarotid Neuroprotection System, ESPRIT, EkoSonic, GELWEAVE, GLIDESHEATH SLENDER, General - Vascular Intervention, IRRISEPT, Integra, Integra Dermal Regeneration Template, MATRIDERM, NOVOSORB BTM, OUTBACK, PAXLOVID, PHOTOFIX DECELLULARIZED BOVINE PERICARDIUM, PRIMATRIX, Penumbra System, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, Restrata Wound Matrix, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, THORAFLEX HYBRID, TREO ABDOMINAL STENT-GRAFT SYSTEM, VISI-PRO, Varithena Administration Pack, Vascular, ZENITH, ZILVER PTX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error